참고문헌
- Park, E. K. and Schuller-Levis, G. B : Taurine : new implication for an old amino acid. FEMS Microbiol. Lett. 226, 195 (2003) https://doi.org/10.1016/S0378-1097(03)00611-6
- Choray, M., Kontny, E., Marcinkiewicz, J. and Maslinski, W. : Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23, 407 (2002)
- Georgia, B., Schuller-Levis, and Eunkyue Park, E. K.: Taurine and Its Chloramine: Modulators of Immunity. Neurochem Res. 29(1), 117 (2004) https://doi.org/10.1023/B:NERE.0000010440.37629.17
- Ibrahim, S. M., Koczan, D. and Thiesen, H. J. : Gene-expression profile of collagen-induced arthritis. J. Autoimmun. 18, 159 (2002)
-
Baura, M., Liu, Y. and Quinn, M. R. : Taurine chloramine inhibits inducible nitric oxide synthase and
$TNF-{\alpha}$ gene expression in activated alveolar macrophages : Decreased NF-kB activation and IkB kinase activity. J. Immunol. 167, 2275 (2002) - Parcell, S. : Sulfur in human nutrition and applications in medicine. Altern. Med. Rev. 7, 22 (2002)
- Sturman, J. A.: Taurine in development. Physical Rev. 73, 119 (1993)
- Englaro, W., Bertolotto, C, Busca, R., Brunet, A., Pages, G., Ortonne, J. P. and Ballotti, R. : Inhibition of the mitogen-activated protein kinase pathway triggers B16 melanoma cell differentiation. J. Biol Chem. 273, 9966 (1998)
- Kim, D. S., Hwang, E. S., Lee, J. E., Kim, S. Y., Kwon, S. B. and Park, K. C. : Sphingosin-1-phophate decrease melanin synthesis via sustained ERK activation and subsequent MITF degradation. J. Cell Sci. 116, 1699 (2003) https://doi.org/10.1242/jcs.00366
- Kim, D. S., Kim, S. Y., Chung, J. H., Kim, K. H., Eun, H. C. and Park, K. C. : Delayed ERK activation by ceramide reduces melanin synthesis in human melanocytes. Cell Signal. 14, 779 (2002)
- Englaro, W., Rezzonico, R., Durand-Clement, M., Lallemand, D., Ortonne, J. P. and Ballotti, R. : Mitogen-activated protein kinase pathway and AP-1 are activated during cAMP-induced melanogenesis in B-16 melanoma cells. J. Biol. Chem. 270, 24315 (1995)
-
Kim, D. S., Park, S. H. and Park, K. C. : Transforming growth
$factor-{\beta}1$ decreases melanin synthesis via delayed extracellular signal-regulated kinase activation. Int. J. Biochem. Cell Biol. 36, 1482 (2004) - Kim, D. S., Park, S. H., Kwon, S. B., Na, J. I., Huh, C. H. and Park, K. C.: Additive effects of heat and p38 MAPK inhibitor treatment on melanin synthesis. Arch. Pharm. Res. 30(3), 581 (2007) https://doi.org/10.1007/BF02977652
- Roser, B. and Robert, B.: Cyclic AMP a key messenger in the regulation of skin pigmentation. Pigment. Cell Res. 13, 60 (2000)
- Bertolotto, C, Busca, R., Abbe, P., Bille, K., Aberdam, E. and Ortonne, J. P. et al.: Different cis-acting elements are involved in the regulation of TRP1 and promoter activities by cyclic AMP: Pivotal role of M boxes (GTCATGTGCT) and of microphthalmia. Mol Cell Biol. 18, 694 (1998)
- Vistica, D. T., Skehan, R, Scudiero, D., Monks, A., Pittman, A. and Boyd, M. R. : Tetrasodium-based assays for cellular viability a critical examination of selected parameters affecting formazan production. Cancer Res. 51, 2515 (1991)
- Martinez-Esparza, M., Jimenez-Cervantes, C., Beermann, F., Aparicio, P., Lozano, J. A. and Garcia-Borron, J. C. : Transforming growth factor-betal inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1. J. Biol. Chem. 272, 3967 (1997)
- Martinez-Esparza, M., Ferrer, C., Castells, M. T., Garcia-Borron, J. C. and Zuasti, A. : Transforming growth factor beta 1 mediates hypopigmentation of B16 mouse melanoma cells by inhibition of melanin formation and melanosome maturation. Int. J. Biochem. Cell Biol. 33, 971 (2001)
- Busca, R., Abbe, E, Mantoux. E, Aberdam, E., Eychene, A., Ortonne, J. P. and Ballotti, R. : B-Raf mediates the cAMP activation of MAPK in B16 melanoma cells. Pigment Cell Res. Suppl 7, 106 (1999)
- Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G. and Goding, C. R. : The microphthalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene 10, 123 (1995)